Table 2.
Imidacloprid: Flumethrin 1.85: 1 | Flumethrin | Imidacloprid | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
[μg/cm2] | 24 h | 48 h | 24 h | 48 h | 24 h | 48 h | ||||||
Mortality | Efficacy | Mortality | Efficacy | Mortality | Efficacy | Mortality | Efficacy | Mortality | Efficacy | Mortality | Efficacy | |
5 | 100 | 100 | 100 | 100 | 75 | 100 | 100 | 100 | 30 | 100 | 100 | 100 |
1 | 100 | 100 | 100 | 100 | 60 | 100 | 80 | 100 | 25 | 90 | 100 | 100 |
0,2 | 80 | 100 | 100 | 100 | 40 | 100 | 70 | 100 | 0 | 60 | 80 | 100 |
0,04 | 40 | 80 | 60 | 100 | 30 | 60 | 60 | 100 | 0 | 30 | 40 | 100 |
0,008 | 0 | 30 | 30 | 60 | 0 | 0 | 0 | 40 | 0 | 0 | 0 | 0 |
0,0016 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
0,00032 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
0,000064 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
min | -1,582 | -2,287 | -0,078 | -0,011 | -4,929 | -1,243 | -3,390 | 0,031 | -1,531 | -0,914 | -1,752 | -0,012 |
max | 100,5 | 100,4 | 103,8 | 100,0 | 100,0 | 99,9 | 93,7 | 100,0 | 100,0 | 101,0 | 106,0 | 100,0 |
ED50 μg/cm2 | 0,059 | 0,012 | 0,033 | 0,008 | 0,483 | 0,010 | 0,039 | 0,009 | 0,537 | 0,074 | 0,112 | 0,017 |
Slope | 1,296 | 1,285 | 1,111 | 3,889 | 0,363 | 1,736 | 1,031 | 4,006 | 17,378 | 1,433 | 0,937 | 3,315 |
ED50 Factor (FI = 1) | 8,2 | 0,9 | 1,2 | 1,2 | 9,1 | 6,4 | 3,4 | 2,3 | ||||
Normality* Test (Shapiro-Wilk) | Passed | Passed | Passed | Passed | Passed | Passed | Passed | Passed | Passed | Failed | Passed | Passed |
P-values* 24 h mortality vs untreated control | 0.028 | 0.004 | 0.0457 | |||||||||
P-values* FI vs F or I | - | 0.0094 | -0.0024 | |||||||||
P-values* F vs I | - | - | -0.0027 |
* Normality and two-sided paired t-test was perfomed for data used in Figure 4 with all data from both trials, means of the two trials were used for curve fitting and fit statistics using SigmaPlot for Windows 11.0 (Build 11.0.0.75, © 2008 Systat Software, Inc.)